Handelsbanken Fonder AB »

Summit Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $707k 34k 20.67
2025-06-30 $728k 34k 21.29
2025-03-31 $716k 37k 19.30
2024-12-31 $662k 37k 17.84
2024-09-30 $1.9M 88k 21.90
2024-06-30 $498k 64k 7.79